Guru Ownership Trend
Guru Analysis for Abbott Laboratories (ABT)
Abbott Laboratories (ABT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 14 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.99 B.
Top institutional holders include Ken Fisher and Jeremy Grantham.
Notably, Robert Bruce has expressed high conviction in this stock, allocating 5.55% of their equity portfolio to it.
Institutional sentiment is currently Bearish. This is evidenced by a $80.06 M net outflow during the quarter.
Recent activity highlights Ray Dalio who increased their stake by 109.6%. Conversely, Cliff Asness reduced exposure by 37.8%.
| Portfolio Manager | % Portfolio | Activity | Shares | Value | Report Date |
|---|---|---|---|---|---|
| 0.58% | Add 1.4% | 12,032,884 | $1.61 B | Q3 2025 | |
| 3.09% | Add 4.6% | 8,176,484 | $1.1 B | Q3 2025 | |
| 3.56% | Reduce -5.2% | 5,603,583 | $750.54 M | Q3 2025 | |
| 0.10% | Reduce -37.8% | 1,159,579 | $154.36 M | Q3 2025 | |
| 0.91% | Reduce -19.9% | 722,884 | $96.82 M | Q3 2025 | |
| 5.55% | 133,800 | $17.92 M | Q3 2025 | ||
| 0.06% | Add 109.6% | 119,235 | $15.97 M | Q3 2025 | |
| 1.26% | Reduce -0.9% | 67,153 | $8.99 M | Q3 2025 | |
| 0.04% | Reduce -17.7% | 64,588 | $8.65 M | Q3 2025 | |
| 0.03% | Add 28.9% | 51,041 | $6.84 M | Q3 2025 | |
| 0.03% | Reduce -4.3% | 22,358 | $2.99 M | Q3 2025 | |
| 0.02% | 11,510 | $1.54 M | Q3 2025 | ||
| 0.02% | 10,459 | $1.4 M | Q3 2025 | ||
| 0.00% | New Buy | 155 | $20,761 | Q3 2025 |
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Portfolio Manager | Option Type | % Portfolio | Activity | Shares | Value | Report Date |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Abbott Laboratories (ABT)
Major holders include Ken Fisher ($1.61 B), Jeremy Grantham ($1.1 B), Diamond Hill Capital ($750.54 M). According to the latest reported data, 14 tracked investment managers collectively hold approximately 28.18 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $80.06 M, with 5 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 6 managers trimmed their positions, while 0 fully exited ABT. The total reported sell value was $161.22 M.
Yes, 1 managers opened new positions in ABT, and 4 increased their existing holdings. The total reported buy value was $81.16 M.